Literature DB >> 23115497

Drug research and treatment for children in Canada: A challenge.

Michael J Rieder.   

Abstract

Historically, children have been 'therapeutic orphans'. Many drugs have not been studied or labelled for use in children and adolescents, making the development and definition of optimally safe and effective drug therapies for the paediatric age group an ongoing challenge. Over the past decade, networks have developed in the United States and Europe to enhance drug research for this group, while no comparable evolution has occurred in Canada. The present statement provides context for the Canadian situation and makes recommendations that address two pressing needs: for more drug research focused on Canadian children and adolescents, including dedicated support for such research; and for increasing human capacity to undertake targeted studies. These initiatives should be undertaken collaboratively, nationally and internationally, and include strategic, innovative approaches to the unique problems and ethical issues posed by drug research in this population.

Entities:  

Keywords:  Canada; Children; Drugs; Research

Year:  2011        PMID: 23115497      PMCID: PMC3223893          DOI: 10.1093/pch/16.9.560

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  7 in total

1.  Canadian Association of Gastroenterology position statement regarding the use of thiopurines for the treatment of inflammatory bowel disease.

Authors:  John K Marshall; Anthony R Otley; Waqqas Afif; Charles N Bernstein; Lawrence Hookey; Grigorios Leontiadis; Remo Panaccione; Brian Bressler
Journal:  Can J Gastroenterol Hepatol       Date:  2014 Jul-Aug

Review 2.  Rising antipsychotic prescriptions for children and youth: cross-sectoral solutions for a multimodal problem.

Authors:  Nina Di Pietro; Judy Illes
Journal:  CMAJ       Date:  2014-03-24       Impact factor: 8.262

Review 3.  Public drug policy for children in Canada.

Authors:  Avram E Denburg; Wendy J Ungar; Mark Greenberg
Journal:  CMAJ       Date:  2017-07-31       Impact factor: 8.262

4.  Pharmacogenomics in Children.

Authors:  Michael J Rieder; Abdelbaset A Elzagallaai
Journal:  Methods Mol Biol       Date:  2022

5.  Pediatric drug data in Canadian drug monographs: a descriptive analysis.

Authors:  Preeya Raja; Mark Duffett; Maryann Mazer-Amirshahi; Ashaka Patel; Andrea Gilpin; Catherine Litalien; Anthony K Chan; John van den Anker; Thierry Lacaze-Masmonteil; Samira Samiee-Zafarghandy
Journal:  CMAJ Open       Date:  2020-08-31

Review 6.  Pharmacogenomics and adverse drug reactions in children.

Authors:  Michael J Rieder; Bruce Carleton
Journal:  Front Genet       Date:  2014-04-16       Impact factor: 4.599

7.  Intravenous ketorolac versus morphine in children presenting with suspected appendicitis: a pilot single-centre non-inferiority randomised controlled trial.

Authors:  Mohamed Eltorki; Jason W Busse; Stephen B Freedman; Graham Thompson; Karen Beattie; Claudiu Serbanescu; Redjana Carciumaru; Lehana Thabane; Samina Ali
Journal:  BMJ Open       Date:  2022-04-05       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.